Perioperative Anxiety Risk Factors in Parents of Children Undergoing Thoracic Surgery
Launched by NATIONAL INSTITUTE FOR TUBERCULOSIS AND LUNG DISEASES, POLAND · Feb 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the anxiety that parents feel before and after their children undergo thoracic surgery, which involves operations on the chest area. The researchers want to identify the factors that contribute to this anxiety, especially those that can be changed or improved. By understanding these factors, they aim to create tailored support for parents, helping them manage their anxiety and ultimately benefiting their child's recovery process after surgery.
To participate in this study, parents must have a child under 18 years old who is scheduled for thoracic surgery and will receive certain types of pain relief after the operation. The study is open to all parents but is currently only recruiting Polish nationals. Participants will be asked about their anxiety levels and how satisfied they are with the pain management their child receives after surgery. This trial is important because it focuses on helping parents cope better during a challenging time, which can also positively affect their child’s healing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • parent of child \<18 years
- • parent of child undergoing thoracic surgery
- • parent of child with intravenous or epidural postoperative analgesia
- • parent of child with 1-3 score according to the American Society of Anesthesiologists
- Exclusion Criteria:
- • a parent of a nationality other than Polish
- • difficult communication with parent
- • parent of a child undergoing oncological treatment
- • parent of a child without chest drainage
- • lack of parental consent.
About National Institute For Tuberculosis And Lung Diseases, Poland
The National Institute for Tuberculosis and Lung Diseases (NITLD) in Poland is a premier research institution dedicated to the prevention, diagnosis, and treatment of respiratory diseases, particularly tuberculosis and other lung-related conditions. As a clinical trial sponsor, NITLD plays a pivotal role in advancing medical research through innovative studies aimed at improving patient outcomes and public health. The institute combines rigorous scientific methodologies with a commitment to ethical standards, ensuring that its clinical trials contribute valuable insights to the global medical community while adhering to the highest regulatory requirements. With a focus on collaboration and excellence, NITLD is at the forefront of respiratory disease research in Poland and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Warsaw, Mazowieckie, Poland
Patients applied
Trial Officials
Lucyna Tomaszek, PhD
Principal Investigator
National Institute for Tuberculosis and Lung Diseases, Poland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials